Wolverine Asset Management’s Evolent Health EVH Stock Holding History

Wolverine Asset Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-487	Closed	-$1.95K	–	1766
2025 Q4	$1.95K	Hold	487	–	–	﹤0.01%	1541
2025 Q3	$4.12K	Hold	487	–	–	﹤0.01%	1442
2025 Q2	$5.48K	Buy	+487	New	+$4.47K	﹤0.01%	1431
2023 Q3	–	Sell	-144	Closed	-$4.36K	–	1901
2023 Q2	$4.36K	Hold	144	–	–	﹤0.01%	1490
2023 Q1	$4.67K	Buy	+144	New	+$4.55K	﹤0.01%	1553
2019 Q4	–	Sell	-34,150	Closed	-$277K	–	1404
2019 Q3	$245K	Sell	34,150 -245,690	-88%	-$1.76M	﹤0.01%	955
2019 Q2	$2.22M	Buy	+279,840	New	+$3.31M	0.03%	410
2017 Q3	–	Sell	-25,000	Closed	-$515K	–	1378
2017 Q2	$633K	Buy	+25,000	New	+$601K	0.01%	722

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wolverine Asset Management's EVH Position: Q1 2026 in Review

Wolverine Asset Management sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 487 shares — an estimated $1.95K sold.

Wolverine Asset Management first reported a position in EVH in Q2 2017 and held it in 8 quarters. The position peaked at $2.22M in Q2 2019. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

Wolverine Asset Management reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
Wolverine Asset Management sold 487 Evolent Health shares in Q1 2026, an estimated $1.95K.
Wolverine Asset Management first reported a position in Evolent Health in Q2 2017 and held it in 8 quarters.
Wolverine Asset Management's Evolent Health position peaked at $2.22M in Q2 2019.
192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.